drugset / Trial / NCT04280263

Caffeine Study for Pain Control Following Total Joint Replacement

NCT04280263

Unknown 70 enrolled Rothman Institute Orthopaedics
RandomizedParallel-groupDouble-blindTreatment

Summary

A prospective, double blinded, single center, randomized controlled study to evaluate the efficacy of caffeine in combination with acetyl salicylic acid (ASA) in the management of postoperative pain in patients undergoing total joint arthroplasty.

Timeline

Start
2020-02-28
Primary completion
2021-06
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Caffeine Small molecule 150 mg

Indications

No indication recorded.